Mylan's EpiPen Pricing Scandal: From Monopoly to Multiplicity
Mylan's EpiPen Pricing Scandal has caused a lot of controversy and raised several questions about the company's marketing strategies, pricing decisions, and ethical practices. In this article, we will explore how Mylan used marketing to increase sales of the EpiPen, why they released a generic version of the EpiPen, and their use of lobbying to promote the product. We will also discuss the estimated marginal cost of producing an EpiPen, the benefits Mylan received from the Epipen-Schools program, and why they misclassified the EpiPen as a generic drug. Additionally, we will examine whether Mylan had a monopoly for life-saving treatments to anaphylactic reactions between 2007 and 2016, their total market share, and the sales generated. Furthermore, we will look at the concessions Mylan made in response to public backlash over the price increases, the reason they were asked to testify at a congressional committee, and some of the lawsuits against Mylan. Finally, we will compare the price of an EpiPen in the United States to prices in other countries.
Read the following articles and answer the following questions:
1. How did Mylan use marketing to increase sales of the EpiPen?
2. Why did Mylan release a generic version of the EpiPen?
3. Discuss Mylan's use of lobbying to increase sales of the EpiPen.
4. What is the estimated marginal cost of producing an EpiPen?
5. What benefits did Mylan receive from the Epipen-Schools program?
6. Why would Mylan misclassify the EpiPen as a generic drug?
7. Between 2007 and 2016, did Mylan have a monopoly for life-saving treatments to anaphylactic reactions?
8. What was their total market share, and how much did this represent in sales?
9. In response to public backlash over the price increases, what concessions did Mylan make?
10. Why was Mylan asked to testify at a congressional committee?
11. What were some of the lawsuits against Mylan?
12. According to Mylan's CEO, what was the reason for the price increase?
13. How does the price of an EpiPen in the United States compare to prices in other countries?